 "moderna")
Moderna Inc said on Wednesday smaller volume agreements for its experimental coronavirus vaccine have been priced in the range of $32 to $37 per dose, higher than the price set by the U.S. deal for Pfizer Inc's vaccine candidate.
As the race to develop Covid-19 vaccines reach a decisive stage, with several candidates being tested in pivotal late-stage studies, pricing has come under increasing scrutiny.
"We will be responsible on price well below (its) value during the pandemic," Chief Executive Officer Stephane Bancel said on a conference call, adding that larger volume agreements for its vaccine will be priced lower.
